- Management of primary and secondary tumours of the central nervous system, eyes and pediatric malignancies
- Methods of optimizing radiation treatment for malignancies of the brain by conformal radiation therapy and/or sensitizing agents
- Determining the value of stereotactically directed radiation therapy for primary tumours of the eye
- Investigating predictive values of MRI spectroscopy/PET changes relative to recurrence patterns of malignant glioma in brain
Normand J Laperriere
Pediatr Blood Cancer. 2018 Jan 25;:
Cochrane Database Syst Rev. 2018 Jan 25;1:CD003869
Trigeminal nerve integrated dose and pain outcome after gamma knife radiosurgery for trigeminal neuralgia.
J Radiosurg SBRT. 2012;1(4):295-301
Can J Neurol Sci. 2017 Dec 18;:1-7
Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival.
Pract Radiat Oncol. 2017 Jun 29;:
Chin Clin Oncol. 2017 Aug;6(4):39
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
J Neurooncol. 2017 Aug 19;:
J Clin Oncol. 2015 Oct 10;33(29_suppl):194
Nat Commun. 2017 Aug 04;8(1):186
N Engl J Med. 2017 06 01;376(22):2197
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre
Associate Director, Gerry and Nancy Pencer Brain Tumour Centre, Princess Margaret Cancer Centre